Viewing Study NCT04319757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:54 PM
Ignite Modification Date: 2026-05-16 @ 7:40 AM
Study NCT ID: NCT04319757
Status: COMPLETED
Last Update Posted: 2024-12-05
First Post: 2020-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors
Sponsor: Acepodia Biotech, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Solid Tumor View
None Metastatic Cancer View
None Solid Tumor View
None HER2-positive Gastric Cancer View
None HER2-positive Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NK Cell Therapy View
None Cellular Therapy View
None Breast Cancer View
None Gastric Cancer View
None Ovarian Cancer View
None Endometrial Cancer View
None Metastatic Cancer View
None Colorectal Cancer View
None Head and Neck Cancer View
None Pancreatic Cancer View
None Bladder Cancer View
None Non-small-cell Lung Carcinoma View